D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PMVP holding history
PMV Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PMVP overviewAll 13F holders of PMVPFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −55,718−100.0% | Sold out | Holders |
| Q3 2025 | 55,718 | $78.0K | <0.1% | −591,911−91.4% | Reduced | Holders |
| Q2 2025 | 647,629 | $686.5K | <0.1% | −302,097−31.8% | Reduced | Holders |
| Q1 2025 | 949,726 | $1.04M | <0.1% | −74,562−7.3% | Reduced | Holders |
| Q4 2024 | 1,024,288 | $1.55M | <0.1% | −16,189−1.6% | Reduced | Holders |
| Q3 2024 | 1,040,477 | $1.55M | <0.1% | +20,849+2.0% | Added | Holders |
| Q2 2024 | 1,019,628 | $1.65M | <0.1% | +298,993+41.5% | Added | Holders |
| Q1 2024 | 720,635 | $1.23M | <0.1% | +472,130+190.0% | Added | Holders |
| Q4 2023 | 248,505 | $770.4K | <0.1% | +219,707+762.9% | Added | Holders |
| Q3 2023 | 28,798 | $176.8K | <0.1% | −32,473−53.0% | Reduced | Holders |
| Q2 2023 | 61,271 | $383.6K | <0.1% | +6,414+11.7% | Added | Holders |
| Q1 2023 | 54,857 | $261.7K | <0.1% | +38,890+243.6% | Added | Holders |
| Q4 2022 | 15,967 | $138.9K | <0.1% | +15,967 | New | Holders |